Search research articles
Contact Us
Filters
Showing results (511-520 of 574) with videos related to
Page
of 58
Sort By:
Acta Neuropathologica
|
February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool, Andrey Korshunov, Marc Remke, et al.
Genome Announcements
|
May 14, 2016
Complete Genome Sequences of Zika Virus Strains Isolated from the Blood of Patients in Thailand in 2014 and the Philippines in 2012
D W Ellison, J T Ladner, R Buathong, et al.
Cold Spring Harbor Molecular Case Studies
|
October 13, 2019
Enrichment of heterozygous germline <i>RECQL4</i> loss-of-function variants in pediatric osteosarcoma
Jamie L Maciaszek, Ninad Oak, Wenan Chen, et al.
Nature
|
July 20, 2010
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Robert A Johnson, Karen D Wright, Helen Poppleton, et al.
Nature Communications
|
September 29, 2018
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
Michael Rusch, Joy Nakitandwe, Sheila Shurtleff, et al.
Human Mutation
|
July 24, 2013
Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays
Andrey Shuvarikov, Ian M Campbell, Piotr Dittwald, et al.
Nature Genetics
|
March 10, 2009
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A Northcott, Yukiko Nakahara, Xiaochong Wu, et al.
The Journal of Investigative Dermatology
|
October 1, 2014
The genomic landscape of childhood and adolescent melanoma
Charles Lu, Jinghui Zhang, Panduka Nagahawatte, et al.
Cancer Cell
|
December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
Acta Neuropathologica
|
May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
Maximilian Y Deng, Martin Sill, Jason Chiang, et al.
Page
of 58
Search research articles
Search
Showing results (511-520 of 574) with videos related to
Sort By:
Page
of 58
Acta Neuropathologica
|
February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool, Andrey Korshunov, Marc Remke, et al.
Genome Announcements
|
May 14, 2016
Complete Genome Sequences of Zika Virus Strains Isolated from the Blood of Patients in Thailand in 2014 and the Philippines in 2012
D W Ellison, J T Ladner, R Buathong, et al.
Cold Spring Harbor Molecular Case Studies
|
October 13, 2019
Enrichment of heterozygous germline <i>RECQL4</i> loss-of-function variants in pediatric osteosarcoma
Jamie L Maciaszek, Ninad Oak, Wenan Chen, et al.
Nature
|
July 20, 2010
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Robert A Johnson, Karen D Wright, Helen Poppleton, et al.
Nature Communications
|
September 29, 2018
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
Michael Rusch, Joy Nakitandwe, Sheila Shurtleff, et al.
Human Mutation
|
July 24, 2013
Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays
Andrey Shuvarikov, Ian M Campbell, Piotr Dittwald, et al.
Nature Genetics
|
March 10, 2009
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A Northcott, Yukiko Nakahara, Xiaochong Wu, et al.
The Journal of Investigative Dermatology
|
October 1, 2014
The genomic landscape of childhood and adolescent melanoma
Charles Lu, Jinghui Zhang, Panduka Nagahawatte, et al.
Cancer Cell
|
December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
Acta Neuropathologica
|
May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
Maximilian Y Deng, Martin Sill, Jason Chiang, et al.
Page
of 58